Searched for
PARACETAMOL API PRICE
API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...- Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
- Centre looks to trigger 'Essentials' Act to regulate prices of bulk drugsDrug prices in India: The department of pharmaceuticals (DoP) has been holding meetings with industry executives to take stock of the situa...
- Painkiller, antibiotic prices set for marginal increase starting April 1Starting April 1, the prices of essential medicines will experience an increase of 0.6%. This change aligns with the annual alterations in ...
- Rising costs of key chemicals choke production at drug ingredient makersIndia's bulk-drug manufacturers are facing a severe cost crisis as prices of key solvents and intermediates have surged due to supply disru...
- India pharma production hit by propane shortage; vitamin, hormone supply at riskIndia’s pharmaceutical industry is facing the risk of medicine shortages as a propane gas crunch forces several manufacturing units to part...
- API prices fall sharply, easing pressure on India's pharmaceutical industryIndia's pharmaceutical industry is experiencing relief as active pharmaceutical ingredient (API) prices plummet due to overcapacity and agg...
- Fairfax, Bain look to buy Gujarat API company FarmsonCanadian billionaire Prem Watsa's Fairfax Group and Bain Capital are in competition for a buyout of Farmson Basic Drugs, a leading API make...
- Relief for pharma companies as API prices see a sharp fallIndia's pharmaceutical industry, which is dependent on China for APIs, intermediates and bulk drugs, had seen an exponential price increase...
- Valiant Laboratories gets healthy premium on debut. What should investors do?"Further, the paracetamol API industry is expected to clock a 5-7% CAGR between FY23 and FY27," said analysts, while suggesting investors c...
- Valiant Laboratories fixes price band at Rs 133-140 for its IPOThe company's IPO is completely a fresh equity issue of Rs 1.08 crore shares. About 50% of the offer is reserved for qualified institutiona...
- Don't expect any more pricing pressures going forward: Krishna Prasad ChigurupatiOur supply chains have been quite stable for a long time even though we still continue to buy some products from China.
- Costs of 127 medicines set to go down post NPPA's 5th price capAmong the 127 medications on the NPPA's list are paracetamol, amoxycillin, rabeprazole, and metformin. Patients frequently make use of many...
- Indian companies are paying up to 25 per cent more for China APIsKey APIs have become 12-25% costlier in the past few days amid possible supply disruptions that may squeeze margins and raise drug prices, ...
- Costs of raw material for drugs rise by up to 140%API prices of certain drugs like fever and pain relief drug paracetamol and life-saving antibiotic Meropenem (also used for Covid), and ant...
- India urges China to stabilise price of APIs linked to Covid-19Indian pharmaceutical companies source almost 70% of their requirement of Covid-19-related APIs from China. Demand for Covid-19-related med...
- Sigh of relief for pharmaceutical industry: India’s pain eases as China resumes bulk drug suppliesResumption of normal supplies has also calmed worries, at least for now, about the Sino-Indian border standoff affecting imports from China...
- API makers surge up to 110% in 50 days as virus hits Chinese exportsBrokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.
- Pharma cos say shortage loomsCostly imports of ingredients from China may take 20% drugs off shelf.
- Bulk drug cos halve output on soaring ingredient costsFaced with a short supply and sharp increase in cost of raw materials imported from China, bulk drug manufactures in India have started sca...
Load More
